These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2227774)

  • 21. Uneasy alliance--clinical investigators and the pharmaceutical industry.
    Bodenheimer T
    N Engl J Med; 2000 May; 342(20):1539-44. PubMed ID: 10816196
    [No Abstract]   [Full Text] [Related]  

  • 22. Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
    D'Souza P
    Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the cost of new drug development: is it really 802 million dollars?
    Adams CP; Brantner VV
    Health Aff (Millwood); 2006; 25(2):420-8. PubMed ID: 16522582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
    Flecknoe-Brown SC
    Med J Aust; 1995 Apr; 162(8):447. PubMed ID: 7746193
    [No Abstract]   [Full Text] [Related]  

  • 25. Good drug, bad luck: business, regulatory issues can create obstacles for drug development.
    Goldman B
    J Natl Cancer Inst; 2004 Nov; 96(21):1573-4. PubMed ID: 15523084
    [No Abstract]   [Full Text] [Related]  

  • 26. Congress, the FDA, and the fair development of new medications for children.
    McKinney RE
    Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299
    [No Abstract]   [Full Text] [Related]  

  • 27. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry.
    Dorfman HL; Reig LP
    Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876
    [No Abstract]   [Full Text] [Related]  

  • 28. Problems relating to investigational drugs.
    Kelsey O
    Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715
    [No Abstract]   [Full Text] [Related]  

  • 29. THE FOOD AND DRUG ADMINISTRATION'S VIEW OF INVESTIGATIONAL DRUGS.
    MEYERS EL
    Am J Pharm Sci Support Public Health; 1963 Jun; 135():219-29. PubMed ID: 14046043
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of regulation on pharmaceutical research expenditures: a dynamic approach.
    Wiggins SN
    Econ Inq; 1983 Jan; 21(1):115-28. PubMed ID: 10259900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Europe on the brink of direct-to-consumer drug advertising.
    Lancet; 2002 May; 359(9319):1709. PubMed ID: 12049853
    [No Abstract]   [Full Text] [Related]  

  • 32. The relation between clinical investigators and the pharmaceutical industry.
    Kunin CM
    Rev Infect Dis; 1984; 6(1):129-31. PubMed ID: 6710019
    [No Abstract]   [Full Text] [Related]  

  • 33. Drugs of limited commercial value.
    Finkel MJ
    N Engl J Med; 1980 Mar; 302(11):643-4. PubMed ID: 7351925
    [No Abstract]   [Full Text] [Related]  

  • 34. Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
    Bell KD
    Med J Aust; 1995 Apr; 162(8):447; author reply 447-8. PubMed ID: 7746194
    [No Abstract]   [Full Text] [Related]  

  • 35. Dispelling myths about drug research.
    Lancet; 2009 Sep; 374(9692):758. PubMed ID: 19733767
    [No Abstract]   [Full Text] [Related]  

  • 36. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O
    BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014
    [No Abstract]   [Full Text] [Related]  

  • 37. Obstacles and opportunities in new drug development.
    Kaitin KI
    Clin Pharmacol Ther; 2008 Feb; 83(2):210-2. PubMed ID: 18202685
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs with breakthrough status charm investors.
    Senior M
    Nat Biotechnol; 2013 Nov; 31(11):945-7. PubMed ID: 24213748
    [No Abstract]   [Full Text] [Related]  

  • 39. Future shock: drug therapy and the U.S. pharmaceutical industry.
    Ellenhorn MJ
    J Clin Pharmacol; 1975; 15(5-6):385-400. PubMed ID: 1133216
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.